217 related articles for article (PubMed ID: 17990103)
1. New insights into the importance of aminopeptidase A in hypertension.
Mizutani S; Ishii M; Hattori A; Nomura S; Numaguchi Y; Tsujimoto M; Kobayshi H; Murohara T; Wright JW
Heart Fail Rev; 2008 Sep; 13(3):273-84. PubMed ID: 17990103
[TBL] [Abstract][Full Text] [Related]
2. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
3. Aminopeptidase A inhibitors as centrally acting antihypertensive agents.
Bodineau L; Frugière A; Marc Y; Claperon C; Llorens-Cortes C
Heart Fail Rev; 2008 Sep; 13(3):311-9. PubMed ID: 18175217
[TBL] [Abstract][Full Text] [Related]
4. Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats.
Marc Y; Gao J; Balavoine F; Michaud A; Roques BP; Llorens-Cortes C
Hypertension; 2012 Aug; 60(2):411-8. PubMed ID: 22710644
[TBL] [Abstract][Full Text] [Related]
5. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C
Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730
[TBL] [Abstract][Full Text] [Related]
6. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
Marc Y; Boitard SE; Balavoine F; Azizi M; Llorens-Cortes C
Can J Cardiol; 2020 May; 36(5):721-731. PubMed ID: 32389345
[TBL] [Abstract][Full Text] [Related]
7. Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice.
Mitsui T; Nomura S; Okada M; Ohno Y; Kobayashi H; Nakashima Y; Murata Y; Takeuchi M; Kuno N; Nagasaka T; O-Wang J; Cooper MD; Mizutani S
Mol Med; 2003; 9(1-2):57-62. PubMed ID: 12765341
[TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase A inhibitors as potential central antihypertensive agents.
Reaux A; Fournie-Zaluski MC; David C; Zini S; Roques BP; Corvol P; Llorens-Cortes C
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13415-20. PubMed ID: 10557335
[TBL] [Abstract][Full Text] [Related]
9. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C
Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats.
Nomura M; Nomura S; Mitsui T; Suzuki M; Kobayashi H; Ito T; Itakura A; Kikkawa F; Mizutani S
Am J Hypertens; 2005 Apr; 18(4 Pt 1):538-43. PubMed ID: 15831365
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin III in hypertension.
Reaux-Le Goazigo A; Iturrioz X; Fassot C; Claperon C; Roques BP; Llorens-Cortes C
Curr Hypertens Rep; 2005 Apr; 7(2):128-34. PubMed ID: 15748538
[TBL] [Abstract][Full Text] [Related]
12. Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
Marc Y; Hmazzou R; De Mota N; Balavoine F; Llorens-Cortes C
Biomed Pharmacother; 2021 Aug; 140():111682. PubMed ID: 34020248
[TBL] [Abstract][Full Text] [Related]
13. The role of the brain renin-angiotensin system in hypertension: implications for new treatment.
Marc Y; Llorens-Cortes C
Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394
[TBL] [Abstract][Full Text] [Related]
14. Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions.
Keck M; Hmazzou R; Llorens-Cortes C
Curr Hypertens Rep; 2019 May; 21(7):50. PubMed ID: 31115779
[TBL] [Abstract][Full Text] [Related]
15. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL
Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747
[TBL] [Abstract][Full Text] [Related]
16. Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
Marc Y; Hmazzou R; Balavoine F; Flahault A; Llorens-Cortes C
J Hypertens; 2018 Mar; 36(3):641-650. PubMed ID: 28968260
[TBL] [Abstract][Full Text] [Related]
17. Kidney aminopeptidase A and hypertension, part I: spontaneously hypertensive rats.
Healy DP; Song L
Hypertension; 1999 Feb; 33(2):740-5. PubMed ID: 10024338
[TBL] [Abstract][Full Text] [Related]
18. Evolution of a New Class of Antihypertensive Drugs: Targeting the Brain Renin-Angiotensin System.
Llorens-Cortes C; Touyz RM
Hypertension; 2020 Jan; 75(1):6-15. PubMed ID: 31786978
[TBL] [Abstract][Full Text] [Related]
19. High aminopeptidase A activity contributes to blood pressure control in
Morais RL; Hilzendeger AM; Visniauskas B; Todiras M; Alenina N; Mori MA; Araújo RC; Nakaie CR; Chagas JR; Carmona AK; Bader M; Pesquero JB
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H437-H445. PubMed ID: 27940965
[TBL] [Abstract][Full Text] [Related]
20. Circulating aminopeptidase activities in men and women with essential hypertension.
Sánchez-Agesta Ortega R; Arias de Saavedra-Alías JM; Liébana-Cañada A; Sánchez-Muñoz B; Martínez-Martos JM; Ramírez-Expósito MJ
Curr Med Chem; 2013; 20(38):4935-45. PubMed ID: 23931276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
